Sopharma Trading AD (XBUL:SFT) Equity-to-Asset : 0.21 (As of Dec. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Sopharma Trading AD Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Sopharma Trading AD's Total Stockholders Equity for the quarter that ended in Dec. 2024 was лв165 Mil. Sopharma Trading AD's Total Assets for the quarter that ended in Dec. 2024 was лв803 Mil. Therefore, Sopharma Trading AD's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was 0.21.

The historical rank and industry rank for Sopharma Trading AD's Equity-to-Asset or its related term are showing as below:

XBUL:SFT' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.13 Med: 0.16 Max: 0.25
Current: 0.21

During the past 13 years, the highest Equity to Asset Ratio of Sopharma Trading AD was 0.25. The lowest was 0.13. And the median was 0.16.

XBUL:SFT's Equity-to-Asset is ranked worse than
81.98% of 111 companies
in the Medical Distribution industry
Industry Median: 0.44 vs XBUL:SFT: 0.21

Sopharma Trading AD Equity-to-Asset Historical Data

The historical data trend for Sopharma Trading AD's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma Trading AD Equity-to-Asset Chart

Sopharma Trading AD Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Equity-to-Asset

Get a 7-Day Free Trial

0.13

0.15

0.17

0.19

0.21

Sopharma Trading AD Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Equity-to-Asset	Get a 7-Day Free Trial															0.19	0.19	0.21	0.19	0.21

Competitive Comparison of Sopharma Trading AD's Equity-to-Asset

For the Medical Distribution subindustry, Sopharma Trading AD's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sopharma Trading AD's Equity-to-Asset Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Sopharma Trading AD's Equity-to-Asset falls into.

Save Embed

;

Save Embed

;

Sopharma Trading AD Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Sopharma Trading AD's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	164.761	/	803.166
	=	0.21

Sopharma Trading AD's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

Equity to Asset (Q: Dec. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	164.761	/	803.166
	=	0.21

Sopharma Trading AD (XBUL:SFT) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Sopharma Trading AD Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Sopharma Trading AD's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma Trading AD Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma Trading AD (XBUL:SFT) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756

Website

http://www.sopharmatrading.bg

Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.

Sopharma Trading AD Headlines

No Headlines